FIELD: medicine, in particular pharmaceutical composition useful in treatment of cartilage lesions, inflammation, arthritis, etc.
SUBSTANCE: claimed composition contains carrier, diluent or filler, valdecoxib and alpha-2-delta-ligand, selected from babapentin, pregabapentin, 3-(1-aminomethylcyclohexylmethyl)-4H-[1,2,4]oxadiazole-5-one hydrochloride, and (3S,4S)-(1-aminimethyl-3,4-dimethylcyclopentyl)acetic acid. Also disclosed are uses of combination, containing valdecoxib and abovementioned alpha-2-delta-ligand for production of drug and treatment of abovementioned diseases.
EFFECT: agent for more effective treatment.
9 cl, 12 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINATIONS CONTAINING ALPHA-2-DELTA LIGANDS AND SEROTONIN/NORADRENALINE REUPTAKE INHIBITORS | 2004 |
|
RU2320369C2 |
| ALPA-2-DELTA LIGAND FOR LOWER URINARY TRACT SYMPTOMS TREATMENT | 2003 |
|
RU2331438C2 |
| CARDIOPROTECTIVE AGENT AND ITS COMPOSITION | 1995 |
|
RU2166319C2 |
| CYCLOPENTYLACRYLAMIDE DERIVATIVE | 2009 |
|
RU2565070C2 |
| DERIVATIVES OF 3-H-1,2,3-TRIAZOLO-[4,5-D]-PYRIMIDINE, PHARMACEUTICAL COMPOSITION AND METHOD OF THEIR SYNTHESIS | 1996 |
|
RU2174518C2 |
| NEW CRYSTAL AND AMORPHOUS FORM OF TRYAZOL[4,5-d] PYRIMIDINE | 2001 |
|
RU2325391C2 |
| NOVEL CRYSTALLINE FORM OF TRIAZOLO(4,5-d)PYRIMIDINE | 2005 |
|
RU2418802C2 |
| NOVEL INTERMEDIATE COMPOUNDS FOR PRODUCING TRIAZOLO(4,5-d)PYRIMIDINE | 2012 |
|
RU2593201C2 |
| ANALOGS OF VITAMIN D, PHARMACEUTICAL COMPOSITION | 1997 |
|
RU2173682C2 |
| QUINOLINE DERIVATIVES FOR TREATING INFLAMMATORY DISEASES | 2008 |
|
RU2460727C2 |
